EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Folic acid supplementation in women of childbearing age with epilepsy: No association with type or number of antiepileptic drugs

Revital Gandelman-Marton iD, Jacques Theitler

Birth Defects Research · 2024

DOI: 10.1002/bdr2.2283 ↗

At a glance

Journal article in Birth Defects Research, 2024. Written by Revital Gandelman-Marton and 1 co-authors. Institution: Neurology Department, Shamir-Assaf Harofeh Medical Center, Zerifin, Israel. Major MEDLINE topics: Anticonvulsants, Epilepsy. Cited 3 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

For over two decades, a daily folic acid (FA) supplementation has been recommended for women of childbearing age with epilepsy. This recommendation is based on evidence that FA administration before conception and during pregnancy can decrease the risk of fetal malformations in the general population, improve cognitive development, and reduce the risk of autistic traits in children exposed in utero to antiepileptic drugs (AEDs).

Objective

The aim of this study was to evaluate FA supplementation rate in nonpregnant women of childbearing age with epilepsy and its relation to AED type and number.

Methods

We retrospectively reviewed the computerized database and the medical records of all the women who had a first visit to our outpatient epilepsy clinic (Shamir‐Assaf Harofeh Medical Center, Zerifin, Israel) during a 10‐year period (2012–2021).

Results

Only 61 (22%) of 282 nonpregnant women of childbearing age with epilepsy treated with AEDs received FA supplementation. Ninety‐two (33%) of the women were treated with AED polytherapy, and 41 (15%) received valproic acid in monotherapy or polytherapy. FA supplementation rate was higher in women aged ≤40 versus >40 (25% vs. 8.5%) ( p = .004). No correlation was found between FA supplementation and AED type or number.

Conclusions

FA supplementation rate was low and was unaffected by AED treatment. Patient and physician‐targeted interventions should be implemented to increase FA prescription and patient adherence.

Subjects

MeSH terms (MEDLINE)

AnticonvulsantsEpilepsyPregnancyChildHumansFemaleRetrospective StudiesFolic AcidDietary Supplements

Author keywords

epilepsyfolic acidwomen of childbearing age

Substances

AnticonvulsantsFolic Acid

Authors and institutions

  • Neurology Department, Shamir-Assaf Harofeh Medical Center, Zerifin, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

ORCID profiles: Revital Gandelman-Marton

Cite

APA

Gandelman-Marton, R., & Theitler, J. (2024). Folic acid supplementation in women of childbearing age with epilepsy: No association with type or number of antiepileptic drugs. Birth Defects Research. https://doi.org/10.1002/bdr2.2283

Vancouver

Gandelman-Marton R, Theitler J. Folic acid supplementation in women of childbearing age with epilepsy: No association with type or number of antiepileptic drugs. Birth Defects Research. 2024. doi:10.1002/bdr2.2283

BibTeX
@article{GandelmanMarton2024,
  author = {Gandelman-Marton, Revital and Theitler, Jacques},
  title = {Folic acid supplementation in women of childbearing age with epilepsy: No association with type or number of antiepileptic drugs},
  journal = {Birth Defects Research},
  year = {2024},
  doi = {10.1002/bdr2.2283}
}
Start for free →